Skip to Content

77 1140 (Acamprosate Calcium Delayed-Release 333 mg)

Pill with imprint 77 1140 is White, Round and has been identified as Acamprosate Calcium Delayed-Release 333 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Acamprosate is used in the treatment of alcohol dependence and belongs to the drug class drugs used in alcohol dependence. Risk cannot be ruled out during pregnancy. Acamprosate 333 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 77 1140

Acamprosate Calcium Delayed-Release

Imprint
77 1140
Strength
333 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Drugs used in alcohol dependence
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
Inactive Ingredients
silicon dioxide, hypromellose 2910 (6 mPa.s), hypromellose 2910 (5 mPa.s), magnesium stearate, magnesium trisilicate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, polyethylene glycol 400, polyethylene glycol 8000, propylene glycol, sodium starch glycolate type A potato, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-5352 Teva Pharmaceuticals USA, Inc.
42291-0104 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.